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ABSTRACT
Objectives: To determine the clinical differences and factors affecting early pregnancy outcome in the first and early second 
trimester subchorionic hematoma cases.
Material and methods: This study involved with the retrospective analysis and evaluation of 81 cases diagnosed with 
subchorionic hematoma. The patients were grouped according to the gestational periods, symptoms at the time of ad-
mission, ratio of surrounding hematoma to the gestational sac, and whether there was a pregnancy loss. The groups were 
compared according to the clinical features and pregnancy outcomes.
Results: The ratio of surrounding hematoma to the gestational sac in the group with pregnancy loss was significantly higher 
(p = 0.002). When the cut-off value was 35.5%, it could determine the possibility of a complication in pregnancy with 70% 
sensitivity and 75% specificity. Nonspecific pelvic pain were significantly higher in the pregnancy loss group than in the 
other group. Logistic regression analysis was performed to determine the effect of these two parameters on the pregnancy 
outcome. Although the presence of non-specific pelvic pain is more in the group with pregnancy loss; there was no effect 
of on pregnancy outcome (p = 0.141). The risk of pregnancy loss increased 4.5 fold if the ratio of ScH to gestational sac 
was above 35% (p = 0.027).
Conclusions: In the cases of subchorionic hematoma, we concluded that when the ratio of surrounding hematoma to 
the gestational sac increased and when it was accompanied by nonspecific pelvic pain, the hospitalization period of the 
patients increased and the ratio of pregnancy loss was higher.
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INTRODUCTION 
Subchorionic hematoma (ScH) is defined as a cres-
cent-shaped, echo-free area between the chorionic mem-
brane and the myometrium. The incidence ranges from 1.3% 
to 3.1% [1]. It is a rare but serious cause of vaginal bleeding 
that is extremely common in the early gestational weeks. Al-
though its etiology is not known exactly, the increase of 
assisted reproductive techniques and low-molecular-weight 
heparin and aspirin use are among the risk factors [2]. It is 
usually diagnosed in patients admitted due to vaginal bleed-
ing. In addition, non-specific pelvic pain (NsPP), such as low 
back, groin and around of umbilicus pains may accompany 
vaginal bleeding. ScH can be diagnosed in routine ultra-
sonography examinations for asymptomatic patients [3–5]. 
It is generally classified as small, medium, or large according 
to the ratio of the diameter of the hematoma to that of the 
gestational sac [6]. In addition, ScH is also classified accord-
ing to its surrounding ratio to the gestational sac [7]. In cases 
with ScH, early pregnancy complications like missed abor-
tion and spontaneous complete or incomplete abortion and 
late complications of pregnancy, such as premature rupture 
of membranes, preterm delivery, and intrauterine growth 
retardation, have been reported to be more frequent [8–10].
In almost all of the previous studies, the effect of he-
matoma size on early and late pregnancy complications in 
patients with first trimester period ScH was evaluated. The 
study evaluating the effect of NsPP on early complications 
of ScH cases is not available in the literature.
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The aim of this study was to determine the parameters 
that affect the early pregnancy losses except hematoma size 
in the first and early second trimester ScH cases. In our cur-
rent study, we found that pregnancy was more complicated 
in ScH cases with non-specific pelvic pain.
MATERIAL AND METHODS 
The study was approved by the ‘’University Local Eth-
ics Committee’’ before a retrospective file search was con-
ducted for the study. The archive files, ultrasonography 
reports, and image records of 684 patients hospitalized 
with vaginal bleeding in ‘’University Obstetrics and Gyne-
cology Department’’ between January 2015 and October 
2018 were reviewed. We detected total of 106 patients who 
had ultrasonography reports and visual hematoma meas-
urement records. 
A total of 25 ScH cases were excluded from the study 
which pregnancies without a fetal heartbeat on ultrasonog-
raphy reports, multiple pregnancies, and pregnancies as-
sisted by supportive reproduction methods. Because, al-
most all of the pregnancies formed by assisted reproductive 
technique had a history of using acetylsalicylic acid, low 
molecular heparin or depot progesterone.
In addition, other pregnant women who developed 
spontaneous pregnancy but who used acetylsalicylic acid 
(aspirin), low-molecular-weight heparin and warfarin for 
another indication were excluded from the study. Demo-
graphic data like age, gravida, parity, history of surgery, 
and pregnancy formation method were obtained from the 
patients’ anamnesis information. In addition, the patients’ 
initial complaints at the time of admission were determined 
and recorded. In our study, we classified the ScHs according 
to the surrounding ratio to the gestational sac. We compared 
the circumference of the entire gestational sac with the 
gestational sac surface separated from the myometrium, 
and thus we obtained the inclusion ratio of hematomas in 
the gestational sac. We indicated the results as a percentage. 
The ratio of surrounding hematoma to the gestational sac 
was determined using the Generic Area program on the 
GE Voluson P8 device. The measurement of subchorionic 
hematomas is shown in Figure 1. The measurements were 
evaluated by two obstetricians who were not aware of the 
study parameters. The other important parameter was NsPP. 
While evaluating the pain of low back, groin and around 
of umbilicus during pregnancy, all abdominal organs and 
musculoskeletal pathologies should be considered [11]. 
There was no organic pathology to explain the pain we 
identified as NsPP. Patients with musculoskeletal system, 
gastrointestinal and urinary tract pathologies were not 
evaluated as NsPP [12]. In our clinic, three questions are 
asked in the evaluation of the pain around the groin, waist 
and umbilicus in the pregnancy. 
Are these pains present during pregnancy and are they 
new?
Do you need analgesics in case of pain?
Do you wake up from your sleep in pain?
NsPP is added to the diagnosis of patients who give 
a yes response to the first question and either of the other 
two questions.
A gestational period of 42–98 days was classified as first 
trimester, while 99–140 days was classified as early second 
trimester pregnancy. Complications like missed abortion, 
complete or incomplete abortion, and termination of preg-
nancy after amnion fluid loss during the treatment before 
the 20th gestastional week were evaluated within the early 
period pregnancy complication. These pregnancies resulted 
in loss. Pregnant women who reached over 20 weeks were 
accepted as the group without early period complications. 
The patients were grouped as having vaginal bleeding 
and having vaginal bleeding + NsPP according to the symp-
toms at the time of admission. The patients were compared 
according to the gestational age, hematoma size, early com-
plication status, and priority admission symptoms.
Statistics 
The Statistical Package for the Social Sciences, version 
15 (SPSS, Chicago, IL) program was used for the statistical 
analysis. The data were classified as being with or without 
normal distribution using the Kolmogorov–Smirnov test. 
Normally distributed data were evaluated using the in-
dependent sample t-test, while non-normally distributed 
data were compared using the Mann–Whitney U test. The 
Chi-square test was used for categorical variables. The 
level of statistical significance was set as p < 0.05. Receiver 
operating characteristic (ROC) analysis was performed 
to determine the efficiency of the ratio of surrounding 
ScH to the gestational sac in foreseeing the gestational 
results. Logistic regression analysis was used to determine 
Figure 1. USG measurements of ScHs; A. A case of subchorionic 
hematoma (white arrow) surrounding approximately 50% of the 
gestational sac; B. A case of subchorionic hematoma (white arrow) 
that surrounds approximately 30% of the gestational sac; C. A case of 
subchorionic hematoma (white arrow) that surrounds approximately 
10% of the gestational sac; ScH — subchorionic hematoma; CRL 
— crown rump length (Fetus); UC — uterine cavity; F — fetus
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the risk factors affecting pregnancy outcome and to cal-
culate odds ratio. 
RESULTS
The number of pregnant women who were examined 
in the first trimester or early second trimester weeks in the 
University Obstetrics and Gynaecology outpatient clinic 
was 5.889 during the period included in the study. A total of 
106 vaginal bleeding patients were detected. The incidence 
of vaginal bleeding in our clinic was 11.6%. ScH was detected 
in 106 patients with vaginal bleeding. The incidence of ScH 
in patients with vaginal bleeding in our clinic was 15.4%. The 
patients were treated with similar abortion imminence treat-
ments during hospitalization. In our study, pregnancy loss 
was detected in 17 (21%) patients. The other 64 (79%) patients 
did not develop early pregnancy complications, and their 
pregnancies reached the 20th gestational week. The ratio 
of surrounding ScH to the gestational sac was statistically 
lower in the group without pregnancy loss than it was in the 
group with pregnancy loss (p = 0.002). The factors affecting 
pregnancy loss are listed in Table 1. First trimester (49–98 days) 
and early second trimester (99–140 days) pregnancies were 
compared in terms of the symptoms, hospitalization times, 
and ratio of surrounding hematoma to the gestational sac. In 
the first trimester group, 41 (83.7%) patients had vaginal bleed-
ing and 8 (16.3%) had primary symptoms of vaginal bleed-
ing + NsPP. In the early second trimester group, 17 (53.1%) 
patients had vaginal bleeding and 15 (46.9%) had primary 
symptoms of vaginal bleeding + NsPP. The difference between 
the two groups was statistically significant (p = 0.003). The 
hospitalization period in the first trimester group was sta-
tistically lower than that in the early second trimester group 
(p < 0.001). In the first trimester group, the ratio of surround-
ing ScH to the gestational sac was statistically lower than it 
was in the early second trimester group (p = 0.005; Tab. 2). 
The patients were compared according to the symptoms of 
vaginal bleeding and vaginal bleeding + NsPP. In the vaginal 
bleeding + NsPP group, the ratio of surrounding hematoma to 
the gestational sac, duration of hospitalization, and pregnancy 
loss were statistically higher (p = 0.002, p < 0.001, p < 0.001, 
p < 0.001, p < 0.001, respectively). There was no statistically 
significant effect of maternal age on symptoms in the ScH 
cases (p = 0.623; Tab. 3). ROC analysis was performed to de-
termine the efficiency of the ratio of surrounding hematoma 
to the gestational sac in foreseeing gestational results. When 
the cutoff value was 35.5%, it could determine the prognosis 
Table 1. Clinical characteristics of patients according to pregnancy outcomes
Variables No loss of pregnancies Loss of Pregnancies
p
n 64 17
Patients age [year], mean ± SD 26.6 ± 4.7 28.2 ± 4.5 0.222
Gravity n (min–max) 3 (1–5) 4 (1–7) 0.212
Live Children n (min–max) 2 (0–4) 2 (0–4) 0.323
Abortion n (min–max) 0 (0–1) 0 (0–3) 0.296
Pregnancy age [day], mean ± SD 83.5 ± 21.7 96.1 ± 28.3 0.051
Hospitalization time [day], mean ± SD 6.5 ± 3.1 7.9 ± 4.9 0.165
Symptoms
N (%)
Bleeding 51 (79.7) 7 (41.2) 0.002
Bleeding + non-specific pelvic pain 13 (20.3) 10 (58.8)
GS Surrounded by Hematoma, % mean ± SD 26.0 ± 14.9 39.3 ± 15.5 0.002
SD — standard deviation; GS — gestational sac
Table 2. Clinical outcomes of the patients according to the duration of pregnancy





Bleeding 41 (83.7) 17 (53.1)
 0.003
Bleeding & non-specific pelvic pain 8 (16.3) 15 (46.9)
Outcome of pregnancy
N (%)
No loss of pregnancy 41 (83.7) 23 (71.9)
0.202
Loss of pregnancy 8 (16.3) 9 (28.1)
Hospitalization time (day), mean ± SD 5.2 ± 2.6 9.3 ± 3.4  < 0.001
GS Surrounded by Hematoma, % (mean ± SD) 24.915.4 34.8 ± 4.9  0.005
SD — standard deviation; GS — gestational sac
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of negative pregnancy with 70% sensitivity and 75% specificity 
[Area Under the ROC Curve (AUC): 0.727, sensitivity: 70%, speci-
ficity: 75%, 95% CI: 0.590–0.864, p = 0.004; Fig. 2]. In the logistic 
regression analysis to predict the outcome of pregnancy, the 
effect of NsPP was statistically insignificant. However, if the 
percentage of ScH was greater than 35%, the risk of pregnancy 
loss increased by 4.5 times (Wald: 4.881, Odss ratio: 4.527, 95% 
CI: 1.186–17.281, p = 0.027).
DISCUSSION
The hematoma diameter is one of the important pa-
rameters affecting the clinical outcome in ScH cases [1]. 
However, we believe that other parameters other than he-
matoma diameter have important effects on clinical sta-
tus. In this study, we aimed to evaluate the effects of NsPP 
on early complications of pregnancy in patients with abortus 
imminence and subchorionic hematoma. In our current 
study, we found that pregnancy was more complicated 
in ScH cases with NsPP. We think that ScHs are often small 
in the first trimester of pregnancy and complicate pregnancy 
less, and they appear to occur less frequently in early second 
trimester pregnancies, but they complicate these pregnan-
cies more. In addition, we think that the hematoma diameter 
may be larger and pregnancy loss may be higher in pregnant 
women with NsPP accompanied by vaginal bleeding.
The incidence of vaginal bleeding in our clinic was 
11.6%. This result was similar to the literature. In their 
study, Hasan et al. [13], found that the incidence of vagi-
nal bleeding was 7–25%. In another study with a larger 
series of cases, Weiss et al. [14], reported the incidence 
of vaginal bleeding as 14.2%. In our study the incidence 
of SCH in patients presenting with vaginal bleeding was 
15.4%. There is a wide range of data for the incidence of 
SCH in patients with vaginal bleeding in the literature. In 
the review of Pearlstone, this rate is stated in a very wide 
range as 4–22% [15]. This rate suggests that patients pre-
senting with vaginal bleeding should be examined more 
carefully for ScH. We believe that our article will be the 
most accurate information providing data to the literature 
on this subject. 
In our study, we found that the higher the ratio of sur-
rounding hematoma to the gestational sac was, the greater 
the possibility of pregnancy loss became [1, 7, 8, 16]. In their 
study, Bennett et al. [7], used a subjective evaluation includ-
ing large, medium, and small values for the ratio of sur-
rounding hematoma to the gestational sac. They reported 
that the risk of pregnancy loss was three times higher in the 
group with a greater percentage of hematoma than it was 
in the other two groups. Bennett et al used a small, medium 
and large subjective criterion for the diameter of the hema-
toma. In our study, we reported the size of the hematoma 
in terms of percentages according to the gestational sac 
containment.
This numerical value (35.5%) obtained for the ratio of 
surrounding hematoma to the gestational sac would be 
more helpful to obstetricians in predicting the outcome 
of the treatment and complications that may occur in pa-
tients with ScH. In the literature, we have found that many 
studies on ScH were mostly evaluated in the first trimester 
of pregnancy. In these studies, many similar results have 
been obtained in first trimester ScH cases related to symp-
toms, findings, and early and late pregnancy complications 
[17–19]. However, we could not find any study evaluating 
the cases of early second trimester ScH. In our clinical experi-
Figure 2. Receiver operating characteristic (ROC) analysis of 
percentage of subchorionic hematoma surrounding GS in predicting 
pregnancy outcome. The cut-off value for subchorionic hematoma 
surrounding GS was 35.5% while the sensitivity and specificity values 
were 70 and 75%, respectively. Area under the ROC curve (AUC): 0.727, 
sensitivity: 70%, specificity: 75%, 95% CI: 0.590–0.864, p = 0.004;  
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GS Surrounded by 
Hematoma, % (mean ± SD) 22.9 ± 13.1 43.8 ± 11.9 < 0.001
Pregnancy Age (day), 
(mean ± SD) 78.7 ± 21.4 105.0 ± 17.9 < 0.001
Patient Age (year) 
(mean ± SD) 26.8 ± 5.1 27.3 ± 3.8 0.623
Hospitalization time (day), 
(mean ± SD) 5.8 ± 2.7 9.4 ± 4.1 < 0.001
SD — standard deviation; GS — gestational sac
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ence, we have seen a significant number of ScHs in the early 
second trimester of pregnancy. In addition, we observed 
that the symptoms, clinical findings, and complications 
were different in these cases after the first trimester. In our 
study, vaginal bleeding was the most common symptom 
in first trimester ScH cases. There were no other symptom 
frequently associated with vaginal bleeding. However, in 
the early second trimester ScH cases, we found that NsPP 
was frequently accompanied by vaginal bleeding. In early 
second trimester ScH cases, with a percentage of hematoma, 
the duration of hospitalization was longer. In the group with 
vaginal bleeding and NsPP, pregnancy loss was statistically 
higher, but in the logistic regression analysis to predict the 
outcome of pregnancy, the effect of NsPP was statistically 
insignificant. Although the effect of NsPP on early pregnancy 
loss is meaningless in logistic regression analysis; we think 
that clinicians who are evaluating ScHs cases should con-
sider this symptom. The ratio of surrounding hematoma to 
the gestational sac was found to be significantly higher in 
early second trimester ScH cases. As this ratio increases, it 
causes greater separation of the gestational sac from the 
uterine wall. As a result, inflammatory cell infiltration and 
inflammatory mediators will occur more around the ges-
tational sac [20, 21]. These inflammatory mediators result 
in the formation of smooth muscle-tightening molecules, 
such as prostaglandin I2 and thromboxane A2 [22, 23]. We 
think that prostaglandin and thromboxane A2 cause NsPP 
[24]. In addition, the uterus will be larger than normal for the 
gestational week in cases where the ScH is larger [25, 26]. 
We think that the stretched visceral peritoneum of the uterus 
and the inflammatory mediators occurred due to hematoma 
contribute to the formation of NsPP. 
CONCLUSIONS 
ScH was more common in first trimester pregnancies, 
which was found to have a smaller diameter and cause 
fewer complications in pregnancy. Although ScH was less 
common in the early second trimester group, it was found 
to have a larger diameter, so it caused more complications 
in pregnancy. In addition, in cases of ScH, it should be kept 
in mind that the hematoma diameter may be larger and 
pregnancy may be more complicated in cases in which 
vaginal bleeding is accompanied by NsPP. Furthermore, 
NsPP cannot be explained for another reason in ScH, should 
be a stimulant for pregnancy complication. In order to better 
understand the effect of NsPP on early pregnancy losses, 
studies with larger case numbers are needed.
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